Valuation AstraZeneca PLC Buenos Aires S.E.

Stocks

End-of-day quote Buenos Aires S.E. Other stock markets 2026-08-05			5-day change	1st Jan Change
63,425.00 ^ARS	+3.21%		-7.61%	-10.10%

10:18pm	US FDA approves first mRNA flu shot from Moderna	RE
08:12pm	AstraZeneca, Jaguar Land Rover Gain Access to UK's Fast-Track Visa	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	182,034	209,442	209,268	203,171	287,813	251,402	-	-
Change	-	15.06%	-0.08%	-2.91%	41.66%	-12.65%	-	-
Enterprise Value (EV) ¹	206,417	232,365	231,778	227,741	311,187	271,487	264,179	256,384
Change	-	12.57%	-0.25%	-1.74%	36.64%	-12.76%	-2.69%	-2.95%
P/E	1,469x	64.1x	35.4x	29.1x	28.4x	20.9x	18.2x	15.8x
PBR	4.24x	5.65x	5.39x	5.02x	5.96x	4.67x	4.14x	3.52x
PEG	-	0x	0.4x	1.6x	0.6x	1.1x	1.2x	1.1x
Capitalization / Revenue	4.87x	4.72x	4.57x	3.76x	4.9x	3.97x	3.76x	3.53x
EV / Revenue	5.52x	5.24x	5.06x	4.21x	5.3x	4.29x	3.95x	3.6x
EV / EBITDA	27.2x	25.2x	17.1x	13.6x	16x	12.2x	10.8x	9.58x
EV / EBIT	20.8x	17.4x	15.9x	13.5x	16.8x	12.9x	11.4x	10x
EV / FCF	42.4x	26.7x	25.8x	22.9x	26.5x	28.3x	20.4x	17.8x
FCF Yield	2.36%	3.75%	3.88%	4.36%	3.78%	3.54%	4.89%	5.61%
Dividend per Share ²	2.87	2.9	2.9	3.1	3.2	3.325	3.527	3.662
Rate of return	2.44%	2.15%	2.15%	2.37%	1.72%	2.05%	2.18%	2.26%
EPS ²	0.08	2.11	3.81	4.5	6.54	7.76	8.926	10.24
Distribution rate	3,588%	137%	76.1%	68.9%	48.9%	42.8%	39.5%	35.7%
Net sales ¹	37,417	44,351	45,811	54,073	58,739	63,273	66,851	71,299
EBITDA ¹	7,586	9,237	13,580	16,691	19,476	22,269	24,395	26,750
EBIT ¹	9,928	13,350	14,534	16,928	18,478	21,090	23,267	25,566
Net income ¹	112	3,288	5,961	7,035	10,225	11,997	13,645	15,532
Net Debt ¹	24,383	22,923	22,510	24,570	23,374	20,085	12,777	4,982
Reference price ²	117.51	135.16	135.02	131.05	185.60	162.09	162.09	162.09
Nbr of stocks (in thousands)	1,549,159	1,549,528	1,549,926	1,550,317	1,550,726	1,551,024	-	-
Announcement Date	2/10/22	2/9/23	2/8/24	2/6/25	2/10/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.02x	11.84x	24.88x	0.61%	995B
JOHNSON & JOHNSON	28.36x	6.26x	17.51x	2.11%	614B
ABBVIE INC.	31.72x	7.19x	14.9x	2.84%	431B
ROCHE HOLDING AG	19.93x	4.73x	11.72x	2.79%	353B
NOVARTIS AG	21.85x	5.66x	14.11x	2.84%	293B
AMGEN INC.	25.61x	6.68x	11.78x	2.59%	210B
NOVO NORDISK A/S	13.52x	5.15x	10.43x	3.7%	210B
GILEAD SCIENCES, INC.	-48.74x	5.83x	32.22x	2.44%	168B
PFIZER INC.	13.25x	3.14x	7.99x	6.77%	145B
Average	15.50x	6.28x	16.17x	2.96%	379.8B
Weighted average by Cap.	23.50x	7.60x	17.97x	2.24%